A first-of-its-kind study will investigate the use of MDMA-assisted psychotherapy for the treatment of female Hypoactive Sexual Desire Disorder (HSDD).
Mind Cure Health has launched its new “Desire Project”, a clinical research programme that aims to explore the use of MDMA-assisted psychotherapy as a treatment for HSDD – a sexual disorder characterised by low sexual desire and emotional distress not attributable to an existing medical condition or relationship issue.
The condition is estimated to affect 10 per cent of adult women and 14 per cent of premenopausal adult women.
The project team is made up of some of the world’s leading researchers in female sexual desire research and psychedelics research.
CEO and president of Mind Cure, Kelsey Ramsden, commented: “We know that sexual health contributes to overall wellbeing and that studies relating to HSDD suggest that female desire has deep roots in the mind.
“Women’s desire issues have not been adequately addressed to date, and we believe that treatment incorporating MDMA and psychotherapy has real promise as it may target those roots of desire in the mind and unlock healing for women lacking desire.
“MINDCURE has identified a gap in the market, and I think that with the team we have built to execute this project, we can help those seeking improved desire in a new way.”
The company has spent six months designing the clinical research programme, looking at how MDMA may ease fear factors for women, which play a large role in causing female-related sexual disorders that are not treated by current medications on the market.
Chief medical officer at Mind Cure, Dr Joel Raskin, commented: “I’m very excited to lead our team and launch a clinical study for the treatment of female Hypoactive Sexual Desire Disorder. During my decades as a psychiatrist clinician and researcher, I’ve seen first-hand the limitations of existing treatments.
“This is an exciting opportunity to find a potentially more effective and better tolerated treatment for women affected by this disorder.”
